Reply to ‘Comment on “Tumour-agnostic drugs in paediatric cancers”’

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Reference

  1. 1.

    Orbach, D., Brennan, B., De Paoli, A., Gallego, S., Mudry, P., Francotte, N. et al. Conservative strategy in infantile fibrosarcoma is possible: the European Paediatric Soft Tissue Sarcoma Study Group experience. Eur. J. Cancer 57, 1–9 (2016).

    PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge and thank our young patients and their families for their willing participation in early phase clinical trials.

Author information

Affiliations

Authors

Contributions

J.C.C., F.C. and L.V.M. all contributed to the writing, revision and approval of this manuscript.

Corresponding author

Correspondence to Julia C. Chisholm.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent to publish

Not applicable.

Data availability

Not applicable.

Competing interests

J.C.C. has received consultancy fees from Bayer unrelated to the subject of this publication. L.V.M. has received speaker’s fees from Bayer.

Funding information

L.V.M. is supported by the Oak Foundation. J.C.C. and F.C. receive support from the Royal Marsden Cancer Charity. All authors are supported by National Health Service funding to the National Institute for Health Research Biomedical Research Centre of The Royal Marsden Hospital. We acknowledge Experimental Cancer Medicine Centre (ECMC) funding to our Unit.

Additional information

Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chisholm, J.C., Carceller, F. & Marshall, L.V. Reply to ‘Comment on “Tumour-agnostic drugs in paediatric cancers”’. Br J Cancer (2020). https://doi.org/10.1038/s41416-020-01104-z

Download citation

Search